Business Description
Morphic Holding Inc
NAICS : 325412
SIC : 2834
ISIN : US61775R1059
Description
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 300.49 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 33.15 | |||||
| Beneish M-Score | -32.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -79.9 | |||||
| 3-Year EBITDA Growth Rate | -40.7 | |||||
| 3-Year EPS without NRI Growth Rate | -34.7 | |||||
| 3-Year FCF Growth Rate | -20.8 | |||||
| 3-Year Book Growth Rate | 45.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.63 | |||||
| 9-Day RSI | 37.99 | |||||
| 14-Day RSI | 37.9 | |||||
| 6-1 Month Momentum % | 65.04 | |||||
| 12-1 Month Momentum % | -25.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 28.94 | |||||
| Quick Ratio | 28.94 | |||||
| Cash Ratio | 28.43 | |||||
| Days Sales Outstanding | 379.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.8 | |||||
| Shareholder Yield % | -30.99 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -34296.74 | |||||
| Net Margin % | -29192.9 | |||||
| FCF Margin % | -21795.2 | |||||
| ROE % | -26 | |||||
| ROA % | -25.14 | |||||
| ROIC % | -2293.22 | |||||
| ROC (Joel Greenblatt) % | -3126.94 | |||||
| ROCE % | -30.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2169.66 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.05 | |||||
| EV-to-EBIT | -4.05 | |||||
| EV-to-EBITDA | -4.08 | |||||
| EV-to-Revenue | 1389.74 | |||||
| EV-to-Forward-Revenue | 724.06 | |||||
| EV-to-FCF | -6.38 | |||||
| Price-to-Net-Current-Asset-Value | 2.07 | |||||
| Price-to-Net-Cash | 2.11 | |||||
| Earnings Yield (Greenblatt) % | -24.69 | |||||
| FCF Yield % | -7.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MORF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Morphic Holding Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.521 | ||
| EPS (TTM) ($) | -3.49 | ||
| Beta | 1.44 | ||
| Volatility % | 79.81 | ||
| 14-Day RSI | 37.9 | ||
| 14-Day ATR ($) | 1.469846 | ||
| 20-Day SMA ($) | 30.5175 | ||
| 12-1 Month Momentum % | -25.84 | ||
| 52-Week Range ($) | 19.345 - 63.0825 | ||
| Shares Outstanding (Mil) | 50.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Morphic Holding Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Morphic Holding Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Morphic Holding Inc Frequently Asked Questions
What is Morphic Holding Inc(MORF)'s stock price today?
The current price of MORF is $28.75. The 52 week high of MORF is $63.08 and 52 week low is $19.35.
When is next earnings date of Morphic Holding Inc(MORF)?
The next earnings date of Morphic Holding Inc(MORF) is 2024-04-25 Est..
Does Morphic Holding Inc(MORF) pay dividends? If so, how much?
Morphic Holding Inc(MORF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers